Rameda’s 2Q net income rises to EGP 101 mn on stronger gross margins
Rameda revenue grew 9.4% y-o-y in 2Q, driven by tenders and export expansion
Available in your choice of English or Arabic
Rameda revenue grew 9.4% y-o-y in 2Q, driven by tenders and export expansion
A 670% jump in GSK Egypt’s share price — fueled by news belonging to its UK parent — suggests retail…
PLUS: Rameda confirmed a c.USD 70 mn Saudi pharmaceutical plant in partnership with LVP Pharma
The purchase caps a months-long accumulation spree that has cemented LVP as the pharma giant’s largest shareholder
El Nawawy will also head the Investment Ministry’s Export Development Fund
Plus: Eni plans USD 2 bn investment push, Orascom Development and Rameda report 2025 earnings, Halan closes securitization issuance
Plus: EU Commission earmarks EUR 8 mn in wartime relief, desalination plant PPPs
Queue